Phenotypic characterisation of pro-inflammatory monocytes and dendritic cells in peripheral arterial disease

Jörn F Dopheide1, Viviane Obst, Christopher Doppler

  • 1Department of Internal Medicine II, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany. dopheide@uni-mainz.de

Insights

Peripheral arterial disease (PAD) patients exhibit increased proinflammatory monocytes. However, critical limb ischemia (CLI) patients show reduced inflammatory markers on myeloid and plasmacytoid dendritic cells (mDCs and pDCs), suggesting a complex immune response in advanced PAD.

Area of Science:

  • Immunology
  • Vascular Biology
  • Cellular Biology

Background:

  • Atherosclerosis, a chronic inflammatory disease, involves monocytes and dendritic cells (DCs).
  • Peripheral arterial disease (PAD) severity influences immune cell phenotypes.

Purpose of the Study:

  • To phenotypically characterize monocytes, myeloid DCs (mDCs), and plasmacytoid DCs (pDCs) in patients with varying degrees of PAD.
  • To investigate immune cell alterations in intermittent claudication (IC) versus critical limb ischemia (CLI).

Main Methods:

  • Flow cytometry analysis of peripheral blood leukocytes from 60 PAD patients (30 IC, 30 CLI) and 30 controls.
  • Gating strategies to identify and analyze monocytes, mDCs, and pDCs.
  • Assessment of cell surface marker expression (e.g., CD14, CD16, HLA-DR, CD86, CD40).

Main Results:

  • PAD patients displayed a higher proportion of proinflammatory CD14++CD16+ monocytes compared to controls.
  • PAD patients showed increased mDCs and reduced pDCs, altering the mDC/pDC ratio.
  • CLI patients exhibited reduced HLA-DR, CD86, and CD40 expression on both mDCs and pDCs compared to IC patients.

Conclusions:

  • Peripheral blood monocytes adopt a proinflammatory phenotype in PAD.
  • Critical limb ischemia (CLI) is associated with reduced expression of inflammatory markers on dendritic cells.
  • Severe ischemia or prolonged inflammation in CLI may paradoxically attenuate mononuclear cell proinflammatory patterns, potentially impairing immune regulation and disease progression.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Inflammation01:38

Inflammation

Overview
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...